UCSF

ZINC00538550

Substance Information

In ZINC since Heavy atoms Benign functionality
September 26th, 2005 28 Yes

Other Names:

sidone

146939-27-7; C07568; Ziprasidone

146939-27-7; D08687; Zipradon (TN); Ziprasidone (INN)

199191-69-0; D02100; Geodon (TN); Ziprasidone mesylate (USAN); Ziprasidone mesylate hydrate

2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monohydrochloride, monohydrate; 2H-Indol-2-one,5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl_ethyl)-6-chloro-1,3-dihydro-monohydrochloride,monohydrate; 5-(2-(4

2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monomethanesulfonate, trihydrate; 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monomethanesulfonate, trihydrate; Geodon; LS-18339

2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-; C21H21ClN4OS; CP 88059; CP 88059-01; CP-88,059; CP-88,059-01; CP-88,059-1; Geodon; LS-83744; Zeldox; Ziprasidone; Ziprasidone [INN:BAN]; ziprazidone

2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-

2H-INDOL-2-ONE, 5-[2-[4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL]ETHYL]-; 6-CHLORO-1,3-DIHYDRO-,MONOMETHANESULFONATE, TRIHYDRATE

5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)-ethyl)-6-chloroindolin-2-one hydrochloride

5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride

5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride hydrate

5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-onehydrochloridehydrate

5-[2-[4- -1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-onehydrochloride

5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride

5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-onehydrochloride

BENZOISOTHIAZOLYLPIPERAZINYLETHYLCHLOROINDOLINONEHYDROCHLORID

CP-88 059-27

CP-88059

CP-88059-01

CP-88059-1

CP-88059; CP-880591; CP-88059-1; CP-8805927; CP-88059-27

CPD000466328; SAM001246607; ZIPRASIDONE

DNC004454

FDA); Ziprasidone Mesylate (FDA

Geodon

Geodon Oral

Geodon, Zeldox

Geodon; Ziprasidone; Ziprasidone hydrochloride

INN); Ziprasidone HCl (FDA

INN); Ziprasidone HCl (USAN

INN); Ziprasidone Mesylate (FDA

LS-190098

ME-2112

MFCD00866661

MFCD06795476

MFCD09838920

NA

USAN)

USAN); Ziprasidone (BAN

USAN); Ziprasidone Mesylate (FDA

Zeldox

ziprasidona; ziprasidone; ziprasidonum

Ziprasidone

Ziprasidone (BAN

ZIPRASIDONE HCL

Ziprasidone Hydrochloride (FDA

Ziprasidone hydrochloride monohydrate

Ziprasidone mesilate

Ziprasidone Mesylate

Ziprasidone mesylate trihydrate

Ziprasidone mesylate; Ziprasidone mesylate hydrate

Ziprasidone, HCl

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.05 10.91 -50.49 2 5 1 50 413.954 4
Hi High (pH 8-9.5) 2.76 5.93 -5.14 0 2 0 26 220.222 1
Mid Mid (pH 6-8) 4.05 8.68 -11.48 1 5 0 48 412.946 4

Vendor Notes

Note Type Comments Provided By
Target 5-HT Receptor,Dopamine Receptor Selleck Chemicals
ALOGPS_SOLUBILITY 7.18e-03 g/l DrugBank-approved
Purity 95% Fluorochem
Purity 95+% Matrix Scientific
Therapy antipsychotic SMDC Pharmakon
Indications antipsychotic, schizophrenia, bipolar disorder KeyOrganics Bioactives
Patent Database Links EP0790236; EP0965343; EP1157726; EP1181933; EP1256578; EP1547650; EP1576985; EP1627639; EP1671972; EP1700857; EP1745774; EP1787990; EP1844769; EP1879027; EP1884243; EP1889844; EP1892243; EP1946777; EP1970052; EP1975169; US2004142904; US2005009870; US20050 ChEBI
Warnings IRRITANT Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP01200z NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP01200z NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
5HT1A-4-E Serotonin 1a (5-HT1a) Receptor (cluster #4 Of 4), Eukaryotic Eukaryotes 4 0.42 Binding ≤ 10μM
5HT2A-1-E Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 0 0.00 Binding ≤ 10μM
5HT2C-1-E Serotonin 2c (5-HT2c) Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 13 0.39 Binding ≤ 10μM
5HT6R-2-E Serotonin 6 (5-HT6) Receptor (cluster #2 Of 2), Eukaryotic Eukaryotes 76 0.36 Binding ≤ 10μM
ACM1-3-E Muscarinic Acetylcholine Receptor M1 (cluster #3 Of 5), Eukaryotic Eukaryotes 5100 0.26 Binding ≤ 10μM
ADA1A-1-E Alpha-1a Adrenergic Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 1 0.45 Binding ≤ 10μM
ADA1B-1-E Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 12 0.40 Binding ≤ 10μM
ADA1D-1-E Alpha-1d Adrenergic Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 12 0.40 Binding ≤ 10μM
ADA2A-1-E Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 390 0.32 Binding ≤ 10μM
ADA2B-1-E Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 390 0.32 Binding ≤ 10μM
ADA2C-1-E Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 390 0.32 Binding ≤ 10μM
DRD1-2-E Dopamine D1 Receptor (cluster #2 Of 4), Eukaryotic Eukaryotes 10 0.40 Binding ≤ 10μM
DRD3-1-E Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 8 0.40 Binding ≤ 10μM
DRD4-1-E Dopamine D4 Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 39 0.37 Binding ≤ 10μM
HRH1-1-E Histamine H1 Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 510 0.31 Binding ≤ 10μM
KCNH2-1-E HERG (cluster #1 Of 5), Eukaryotic Eukaryotes 151 0.34 Binding ≤ 10μM
Q63380-1-E Transporter (cluster #1 Of 1), Eukaryotic Eukaryotes 48 0.37 Binding ≤ 10μM
SC6A4-1-E Serotonin Transporter (cluster #1 Of 4), Eukaryotic Eukaryotes 53 0.36 Binding ≤ 10μM
KCNH2-1-E HERG (cluster #1 Of 2), Eukaryotic Eukaryotes 152 0.34 Functional ≤ 10μM
DRD2-4-E Dopamine D2 Receptor (cluster #4 Of 24), Eukaryotic Eukaryotes 5 0.42 Binding ≤ 10μM
Z104304-3-O Adrenergic Receptor Alpha-1 (cluster #3 Of 3), Other Other 11 0.40 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
Z104304 Z104304 Adrenergic Receptor Alpha-1 11 0.40 Binding ≤ 1μM
ADA1A_RAT P43140 Alpha-1a Adrenergic Receptor, Rat 0.5 0.47 Binding ≤ 1μM
ADA1A_HUMAN P35348 Alpha-1a Adrenergic Receptor, Human 1.9 0.44 Binding ≤ 1μM
ADA1B_HUMAN P35368 Alpha-1b Adrenergic Receptor, Human 1.9 0.44 Binding ≤ 1μM
ADA1D_HUMAN P25100 Alpha-1d Adrenergic Receptor, Human 1.9 0.44 Binding ≤ 1μM
ADA2A_HUMAN P08913 Alpha-2a Adrenergic Receptor, Human 390 0.32 Binding ≤ 1μM
ADA2B_HUMAN P18089 Alpha-2b Adrenergic Receptor, Human 390 0.32 Binding ≤ 1μM
ADA2C_HUMAN P18825 Alpha-2c Adrenergic Receptor, Human 390 0.32 Binding ≤ 1μM
DRD1_HUMAN P21728 Dopamine D1 Receptor, Human 130 0.34 Binding ≤ 1μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 0.42 0.47 Binding ≤ 1μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 2.8 0.43 Binding ≤ 1μM
DRD3_HUMAN P35462 Dopamine D3 Receptor, Human 10 0.40 Binding ≤ 1μM
DRD4_HUMAN P21917 Dopamine D4 Receptor, Human 32 0.37 Binding ≤ 1μM
KCNH2_HUMAN Q12809 HERG, Human 1000 0.30 Binding ≤ 1μM
HRH1_HUMAN P35367 Histamine H1 Receptor, Human 47 0.37 Binding ≤ 1μM
HRH1_RAT P31390 Histamine H1 Receptor, Rat 150 0.34 Binding ≤ 1μM
5HT1A_HUMAN P08908 Serotonin 1a (5-HT1a) Receptor, Human 2.5 0.43 Binding ≤ 1μM
5HT2A_HUMAN P28223 Serotonin 2a (5-HT2a) Receptor, Human 0.1 0.50 Binding ≤ 1μM
5HT2A_RAT P14842 Serotonin 2a (5-HT2a) Receptor, Rat 0.42 0.47 Binding ≤ 1μM
5HT2C_HUMAN P28335 Serotonin 2c (5-HT2c) Receptor, Human 0.55 0.46 Binding ≤ 1μM
5HT6R_HUMAN P50406 Serotonin 6 (5-HT6) Receptor, Human 61 0.36 Binding ≤ 1μM
SC6A4_HUMAN P31645 Serotonin Transporter, Human 53 0.36 Binding ≤ 1μM
Q63380_RAT Q63380 Transporter, Rat 48 0.37 Binding ≤ 1μM
Z104304 Z104304 Adrenergic Receptor Alpha-1 11 0.40 Binding ≤ 10μM
ADA1A_RAT P43140 Alpha-1a Adrenergic Receptor, Rat 0.5 0.47 Binding ≤ 10μM
ADA1A_HUMAN P35348 Alpha-1a Adrenergic Receptor, Human 1.9 0.44 Binding ≤ 10μM
ADA1B_HUMAN P35368 Alpha-1b Adrenergic Receptor, Human 1.9 0.44 Binding ≤ 10μM
ADA1D_HUMAN P25100 Alpha-1d Adrenergic Receptor, Human 1.9 0.44 Binding ≤ 10μM
ADA2A_HUMAN P08913 Alpha-2a Adrenergic Receptor, Human 390 0.32 Binding ≤ 10μM
ADA2B_HUMAN P18089 Alpha-2b Adrenergic Receptor, Human 390 0.32 Binding ≤ 10μM
ADA2C_HUMAN P18825 Alpha-2c Adrenergic Receptor, Human 390 0.32 Binding ≤ 10μM
DRD1_HUMAN P21728 Dopamine D1 Receptor, Human 130 0.34 Binding ≤ 10μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 0.42 0.47 Binding ≤ 10μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 2.8 0.43 Binding ≤ 10μM
DRD3_HUMAN P35462 Dopamine D3 Receptor, Human 10 0.40 Binding ≤ 10μM
DRD4_HUMAN P21917 Dopamine D4 Receptor, Human 32 0.37 Binding ≤ 10μM
KCNH2_HUMAN Q12809 HERG, Human 6920 0.26 Binding ≤ 10μM
HRH1_RAT P31390 Histamine H1 Receptor, Rat 150 0.34 Binding ≤ 10μM
HRH1_HUMAN P35367 Histamine H1 Receptor, Human 47 0.37 Binding ≤ 10μM
ACM1_HUMAN P11229 Muscarinic Acetylcholine Receptor M1, Human 5100 0.26 Binding ≤ 10μM
5HT1A_HUMAN P08908 Serotonin 1a (5-HT1a) Receptor, Human 2.5 0.43 Binding ≤ 10μM
5HT2A_HUMAN P28223 Serotonin 2a (5-HT2a) Receptor, Human 0.1 0.50 Binding ≤ 10μM
5HT2A_RAT P14842 Serotonin 2a (5-HT2a) Receptor, Rat 0.42 0.47 Binding ≤ 10μM
5HT2C_HUMAN P28335 Serotonin 2c (5-HT2c) Receptor, Human 0.55 0.46 Binding ≤ 10μM
5HT6R_HUMAN P50406 Serotonin 6 (5-HT6) Receptor, Human 61 0.36 Binding ≤ 10μM
SC6A4_HUMAN P31645 Serotonin Transporter, Human 53 0.36 Binding ≤ 10μM
Q63380_RAT Q63380 Transporter, Rat 48 0.37 Binding ≤ 10μM
KCNH2_HUMAN Q12809 HERG, Human 152 0.34 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Adrenaline signalling through Alpha-2 adrenergic receptor
Adrenaline,noradrenaline inhibits insulin secretion
Adrenoceptors
Dopamine receptors
G alpha (12/13) signalling events
G alpha (i) signalling events
G alpha (q) signalling events
G alpha (s) signalling events
G alpha (z) signalling events
Histamine receptors
Muscarinic acetylcholine receptors
Serotonin receptors
Voltage gated Potassium channels

Analogs ( Draw Identity 99% 90% 80% 70% )